FinDogFinDog
Friday, October 30, 2026Closing data · 4:00 PM ET
English
Log in

BAX

Baxter InternationalNYSE · Health Care Equipment · Health Care
Previous close
23.00
Change
−0.50 / −2.13%
FinDog View
Neutral
52-Week Range ?
15.73 – 30.00
P/E (TTM) ?
—
Forward P/E ?
11.6
Based on consensus earnings for the next 12 months
Market Cap
$11.7B
1M
−4.17%
S&P 500 −0.91% over same period
Volume / Avg Volume
11.8M / 7.9M
1.50× average
Latest earnings analysisFY2026 Q2Reported 2026-07-30

Baxter Q2 2026: sales up 5.0%, full-year guidance raised

Baxter beat the $0.37 adjusted-EPS consensus by a wide margin with $0.56 and raised full-year guidance, so the quarter is better than the 5.0% sales growth alone suggests. Read the beat carefully: it leans on a one-time $0.11 per-share tariff refund, adjusted EPS still slipped 5.0% from a year ago, and GAAP net income was just $126 million. That combination is why the view below is Neutral rather than Bullish.

Read the full analysis →
Revenue$2.96BYoY +5.30%
EPS (non-GAAP)$0.56Beatest. $0.37
Next-day move−2.21%

Price History

Closing price · USD1M6M1Y5Y

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis

Next Earnings

Date and consensus from the earnings calendar; the analysis is generated automatically after the releaseEarnings Calendar →
Report date
2027-02-10
in 101 days · After hours
Consensus EPS
$0.62
Last quarter EPS $0.56
Avg. next-day move over the last 6 reports
±2.5%

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
A 5-year P/E range needs a longer earnings record; not yet comparable
Last 4 quarters: $0 in buybacks + $102M in dividends, 0.87% of market cap combined
P/E (TTM)
—
P/B
1.9
P/S
1.0
Dividend Yield
3.22%
Earnings Reaction
Over the last 6 reports, the stock moved ±2.5% on average on the first trading day after, rising 3 times
Most recent −2.21%
Volatility & Correlation
1-year beta 1.15 · Correlation with S&P 500 0.33Tracks the market
Annualized volatility 44% vs. 13% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
No open-market buys or sells by officers or directors in the last 90 days.
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q32.98+5.0%33.4%0.230.290.560.57
FY2026 Q22.96+5.3%34.9%0.220.130.290.24
FY2026 Q12.70+2.9%33.0%0.07-0.020.21-0.03
FY2025 Q42.97+8.0%19.4%-0.73-1.130.58-2.21
FY2025 Q32.84+5.0%33.5%0.17-0.050.24-0.09
FY2025 Q22.81+4.3%35.3%0.190.090.220.18
FY2025 Q12.63+5.4%32.8%0.060.13-0.190.25
FY2024 Q42.75+0.9%——-0.510.49-1.00
FY2024 Q32.70+3.8%38.3%0.160.140.250.27
FY2024 Q22.69+4.0%38.3%0.18-0.310.12-0.61
FY2024 Q12.49+2.0%38.6%0.120.040.160.07
FY2023 Q42.73−27.1%——0.250.530.48

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView